Weekly Rundown: Small-Cap Stocks with Key Catalysts (July 14-18)

This weekly summary highlights recent filings, significant news, and strategic updates from small-cap companies. Review the key developments we're monitoring for the week of July 14–18.

Fireside Chat Participants – H.C. Wainwright 4th Annual Kidney Virtual Conference - Monday, July 14

The following companies are scheduled to participate in fireside chats at this year’s virtual event:

● Akebia Therapeutics (AKBA)

● CalciMedica Inc. (CALC)

● Unicycive Therapeutics (UNCY)

● ProKidney Corp. (PROK)

Presenting Companies – Emerging Growth Conference - Wednesday, July 17

These companies are scheduled to present at the upcoming Emerging Growth Conference:

● Uxin Limited (UXIN)

● Jaguar Health, Inc. (JAGX)

Key Catalysts This Week (July 14–18, 2025)

July 15

● FBLG – Founder & CEO Pete O’Heeron will present at the Advanced Wound Care Summit USA in Boston. The session will highlight recent research advances using fibroblast-based technology for wound healing and psoriasis.

● ANIX – The USPTO will issue U.S. Patent No. 12,357,593, protecting Anixa's ovarian cancer vaccine targeting anti-Müllerian hormone receptor, type II (AMHR2) — a key immunotherapy target.

● NVNI – Final selection event for the NuviniAI Challenge takes place at Oracle's São Paulo office. Ten high-potential internal AI projects will be narrowed down to the top three, which will be fast-tracked for implementation and public launch by year-end.

● STAI – Participating in the 10th Annual Smart Airport Conference & Exposition (July 15–17 in Atlanta, GA), with a focus on advanced infrastructure, automation, and sustainability initiatives.

July 16

● KOD – Hosting a virtual R&D Day webcast (4:00–5:30 PM ET), offering insights into late-phase clinical programs including tarcocimab, KSI-501, and KSI-101, featuring leadership and external experts.

● SQNS – Engaging in a fireside chat with Roth Capital (Scott Searle, Senior Analyst) to discuss the company’s bitcoin treasury strategy and its core semiconductor IoT business.

● INO – Presenting on its next-gen DNA medicine platform for rare diseases at the Orphan Drug Summit in Boston, with a focus on innovation in manufacturing and gene therapy delivery.

● KALA – Hosting a webcast with Key Opinion Leaders (KOLs) at 4:00 PM ET to discuss KPI-012, a potential treatment for Persistent Corneal Epithelial Defect (PCED).

July 17

● HOWL – Dr. Randi Isaacs, CMO, will speak at the KidneyCAN 7th Annual Kidney Cancer Research Summit in Boston, spotlighting the company’s pipeline in renal oncology.

● FFAI – Launching its B2C pre-order campaign at the FX Super One product launch event, which will showcase its first commercial offering.

July 18

● LZM – Will file a Feasibility Study Technical Report Summary for the Kabanga Nickel Project before market open via Form 6-K. The filing will be accessible on EDGAR and the company's investor site.

Looking Ahead: Week of July 21

● LITM – The company’s 50/50 joint venture with Global Uranium and Enrichment Ltd. (GUE) has engaged Single Water Services LLC to execute its initial drilling program at the Pine Ridge Uranium Project in Wyoming. Drilling operations are scheduled to commence on Monday, July 21, marking a key operational milestone for the project.

● KAVL – A decision from the Administrative Law Judge (ALJ) is expected on July 21 in the ongoing ITC investigation related to the Bidi Stick. The ALJ's initial determination (ID) will address claims brought by the RJ Reynolds Entities, who are seeking exclusion and cease-and-desist orders based on alleged patent infringement. While Bidi entered into a consent order in December 2024 agreeing to temporarily cease importation and distribution of the Bidi Stick, the outcome of the ALJ's ruling—and eventual Commission review—will play a pivotal role in determining the future availability of the product in the U.S. A final Commission decision is currently due by November 24, 2025, subject to extension.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.